HEALTHY EXTRACTS INC. (HYEX): M&A transaction — Healthy Extracts acquires Gummy USA LLC, issues 77.5% of stock, Swanson becomes Chairman/President

HEALTHY EXTRACTS INC.

Issued 13,075,920 shares (77.5% of post-transaction common stock) to Donald Swanson for 100% of Gummy USA LLC.
Donald Swanson appointed Chairman, President, and director; Kevin 'Duke' Pitts becomes CEO.
Swanson granted anti-dilution rights to maintain 77.5% ownership upon exercise of 154,306 outstanding options/warrants.
Gummy USA manufactures custom gummy nutritional supplements; financial statements to be filed within 71 days.

item 1.01 item 2.01 item 3.02 item 5.01 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

HEALTHY EXTRACTS INC. underwent a change of control involving Donald Swanson for 13,075,920 shares of our common stock which represents 77.5% of our issued and outstanding common stock after the transaction (closed 2025-07-19).

Action: change of control
Counterparty: Donald Swanson
Consideration: 13,075,920 shares of our common stock which represents 77.5% of our issued and outstanding common stock after the transaction
Closing: 2025-07-19

Exact text from the filing

membership interests of GUSA, which is now our wholly-owned subsidiary. As consideration for the purchase, we issued thirteen million seventy-five thousand nine hundred twenty (13,075,920) shares of our common stock (the “Purchase Shares”) which represents 77.5% of our issued and outstanding common stock after the transaction, to Swanson. In addition, Swanson was

View on SEC.gov

Browse all m&a transactions →

HEALTHY EXTRACTS INC. filing history →

Source: SEC EDGAR

accession 0001096906-25-001186

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.